NRx Pharmaceuticals Inc (NRXPW) — Cash Flow Quality Index

Latest as of December 2025: -10.31x

NRx Pharmaceuticals Inc (NRXPW) has a Cash Flow Quality Index of -10.31x as of December 2025. Operating cash flow of $-3.71 Million is below net income of $360.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of NRx Pharmaceuticals Inc to assess how effectively this company generates cash.

Cash Flow Quality Index

-10.31x
Operating CF / Net Income

Operating Cash Flow

$-3.71 Million
USD

Net Income

$360.00K
USD

Data as of

Dec 2025
Most recent filing

NRx Pharmaceuticals Inc Cash Flow Quality Index (2018–2019)

Historical Cash Flow Quality Index for NRx Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore NRx Pharmaceuticals Inc (NRXPW) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Quality Index for NRx Pharmaceuticals Inc (2018–2019)

Year-by-year earnings quality comparison for NRx Pharmaceuticals Inc. For live market cap and the full company financial profile, see NRx Pharmaceuticals Inc market cap and net worth.

Year Quality Index Operating CF (USD) Net Income YoY Change
2019 -1.94x $-792.73K $408.43K ▲ +72.9%
2018 -7.16x $-473.19K $66.10K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.